COVID-19 pregnancies are associated with increased rates of premature delivery and stillbirths. It is still a matter of debate whether there is a COVID-19-associated pattern of placenta pathology. We updated our previously published results on a systematic literature review and meta-analysis of COVID-19 pregnancies. In total, 38 reports on 3677 placentas were evaluated regarding histopathological changes. Maternal vascular malperfusion (32%), fetal vascular malperfusion (19%), acute and chronic inflammation (20% and 22%) were frequent pathologies. In non-COVID-19 pregnancies, placentas show similar histologic patterns and mainly similar frequencies of manifestation. It has to be taken into account that there might be an observation bias, because some findings are diagnosed as a "pathology" that might have been classified as minor or unspecific findings in non-COVID-19 placentas. COVID-19 placentitis occurs in 1-2% of cases at the most. In conclusion, this updated meta-analysis indicates that COVID-19 infection during pregnancy does not result in an increased rate of a specific placenta pathology and COVID-19 placentitis is rare.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/a-2220-7469 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Double balloon catheter induction of labor in pregnant women with COVID-19 infection.
BMC Pregnancy Childbirth
March 2025
Department of Obstetrics and Gynecology, Maternal and Child Medicine Center affiliated with, Hefei Maternal and Child Health Care Hospital, Anhui Medical University, Hefei, China.
Background: To identify the effectiveness and safety induction using a double-balloon catheter in the setting of Coronavirus disease 2019 (COVID-19) infection.
Methods: This retrospective study included 577 COVID-19-afected women who underwent induction of labor with a double balloon catheter or spontaneously started delivery between December 7, 2022, and June 20, 2023; 154 women underwent induction of labor (double balloon catheter, study group) and 423 women underwent spontaneous started delivery (control group). Maternal and neonatal outcomes and complications during labor were assessed and compared.
Prevalence and Clinical Features of Pulmonary Embolism in Pregnancy and Puerperium in the Post-COVID-19 Era.
Matern Child Health J
March 2025
Department of Internal Medicine, Hospital Tengku Ampuan Rahimah, Ministry of Health, Jalan Langat, Klang, Selangor, 41200, Malaysia.
Objective: Interest in pulmonary embolism (PE) has undergone a renaissance since the emergence of COVID-19 pandemic, but PE researches among pregnant mothers in this post-COVID-19 era remains scarce. This study was conducted to (a) determine PE prevalence rate among pregnant and post-partum women with suspected PE after the COVID 19 pandemic, (b) compare the clinical characteristics, laboratory findings and CT features between the PE and non-PE cohorts, and (c) validate the Pregnancy-Adapted Geneva (PAG) score in our population.
Methods: This retrospective cross-sectional study involved the review of all maternal cases with suspected PE who underwent diagnostic CTPA in year 2022.
Corrigendum: SARS-CoV2 infection during pregnancy causes persistent immune abnormalities in women without affecting the newborns.
Front Immunol
February 2025
Immunology Section, Laboratory of ImmunoBiology Molecular, Hospital General Universitario Gregorio Marañón (HGUGM), HIV-HGM BioBank, Madrid, Spain.
[This corrects the article DOI: 10.3389/fimmu.2022.
View Article and Find Full Text PDFHealthcare utilization in the departments of obstetrics and gynecology during the first two years of the COVID-19 pandemic: time series analysis in Jining, China.
BMC Public Health
March 2025
Public Health Sciences Division, Fred Hutch Cancer Center, 1100 Fairview Ave N., Seattle, WA, USA.
Introduction: Healthcare utilization in China decreased precipitously during the initial outbreak of the COVID-19 pandemic, and women were disproportionately affected. As the COVID-19 pandemic has proven to be far more pervasive and persistent than many first surmised, a vital question is whether the utilization of non-COVID related healthcare has remained low under China's dynamic zero-COVID policy. This study aimed to estimate the initial and enduring collateral effects of the COVID-19 pandemic on the utilization of obstetrics and gynecology care at a tertiary hospital in Jining, Shandong Province, China.
View Article and Find Full Text PDFCOVID-19 Vaccination During Pregnancy and Major Structural Birth Defects.
Pediatrics
March 2025
School of Nursing and Health Professions, University of San Francisco, San Francisco, CA.
Background And Objectives: COVID-19 vaccination is recommended during pregnancy; however, evidence on the prevalence of major structural birth defects born to people vaccinated early in pregnancy (≤20 weeks of gestation) is limited. We compared the prevalence of major structural birth defects by COVID-19 vaccination status and key strata: insurance provider, clinically diagnosed SARS-CoV-2 infection during pregnancy, and concomitant administration of other maternal vaccines. We also compared, head-to-head, the prevalence of birth defects by brand (Moderna mRNA-1273 vs Pfizer-BioNTech BNT162b2).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!